Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Coherus Biosciences ( (CHRS) ) has shared an update.
Kimberly J. Tzoumakas has announced her resignation from the Board of Directors of Coherus BioSciences, Inc., effective December 31, 2024. Her departure is amicable, with no disagreements over company operations or policies, reflecting a positive relationship and her valued contributions during her time with the board.
See more data about CHRS stock on TipRanks’ Stock Analysis page.
Trending Articles
- A New “Anti-Woke ETF” Takes Aim at Starbucks (NASDAQ:SBUX)
- Ford (NYSE:F) Plans New EV Plant Close to Nickel
- The Gelsinger Post-Mortem Starts at Intel (NASDAQ:INTC)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
